Mangalam Drugs & Organics Ltd

MANGALAM

Company Profile

  • Business description

    Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.

  • Contact

    P. D'Mello Road
    Rupam Building, 3rd Floor, No. 239
    Near General Post Office
    MumbaiMH400001
    IND

    T: +91 2222616200

    https://www.mangalamdrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    480

Stocks News & Analysis

stocks

Cheap e-commerce share continues sales momentum

The e-commerce business continues its sales momentum despite challenging backdrop.
stocks

Chart of the Week: Booming mined commodity prices see little value on offer

Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.
stocks

3 ASX top picks to combat inflation

The mechanics behind inflation resilient ASX businesses.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,819.6065.10-0.73%
CAC 408,188.8719.02-0.23%
DAX 4025,092.2585.55-0.34%
Dow JONES (US)50,668.9724.690.05%
FTSE 10010,425.9679.05-0.75%
HKSE25,006.16322.07-1.27%
NASDAQ26,917.47242.740.91%
Nikkei 22564,693.12306.29-0.47%
NZX 50 Index13,191.1214.99-0.11%
S&P 5007,563.6343.270.58%
S&P/ASX 2008,592.9061.60-0.71%
SSE Composite Index4,098.644.910.12%

Market Movers